Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lung Cancer
Clinical trial register · China

Lung Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Guangzhou 39 Shanghai 34 Beijing 25 Chengdu 12 Hangzhou 11
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital of Guangzhou Medical University10 Shanghai Chest Hospital9 Shanghai Pulmonary Hospital, Shanghai, China8 The First Affiliated Hospital of Guangzhou Medical University6 AstraZeneca5
Site location
Guangzhou39 Shanghai34 Beijing25 Chengdu12 Hangzhou11
All 51 locations
Target enrolment
to

Lung Cancer trials in China

135 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2027-06-01
Not yet open
Shanghai Chest Hospital
Not applicable
15
Shanghai
2026-11-13
Not yet open
Video-guided Versus Conventional Right-sided Double-lumen Tube Placement for Thoracoscopic Surgery
NCT07849400Right-sided Double-lumen Tube Positioning, Lung Isolation During Thoracoscopic Surgery, One-lung Ventilation, Lung Cancer
Diansan Su
Not applicable
566
Hangzhou, Jiaxing
2026-10-01
Recruiting
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
NCT07039474Solid Tumor Malignancies, Hematologic Cancer, Lung Cancer, Esophagus Cancer
Peking University First Hospital
Observational
120
Beijing
2026-09-08
Not yet open
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
15
Wuhan
2026-09
Recruiting
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
NCT07760012Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer, Breast Cancer
Peking University Third Hospital
Not applicable
50
Beijing
2026-08-13
Recruiting
TROP2 NMR Concordance Study
NCT07624318Lung Cancer
AstraZeneca
Observational
3,400
Beijing, Guangzhou, Shanghai
2026-08-13
Recruiting
Precision Navigation to Improve Community Cancer Screening Participation
NCT07676383Cancer Screening, Lung Cancer, Breast Cancer, Colorectal Cancer
Hunan Cancer Hospital
Not applicable
1,500
Huaihua, Shaoyang, Yongzhou
2026-08-04
Recruiting
Shanghai Chest Hospital
Observational
294
Shanghai
2026-07-03
Recruiting
AstraZeneca
Observational
2,000
Beijing, Chengdu, Fuzhou, Guangzhou, Nanchang, Shanghai, Shenyang, Shijiazhuang
2026-06-22
Recruiting
Hansoh BioMedical R&D Company
Phase 1
396
Guangzhou
2026-06-15
Not yet open
Peking University Cancer Hospital & Institute
Not applicable
20
Beijing
2026-06-01
Recruiting
Fudan University
Observational
5,390
Shanghai
2026-05-14
Not yet open
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
NCT07014878Colorectal Cancer, Lung Cancer, Pancreatic Cancer
Beijing DCTY Biotech Co.,Ltd.
Phase 1
18
Shanghai
2026-05
Recruiting
AstraZeneca
Phase 2
60
Beijing, Changchun, Changsha, Chengdu, Foshan, Fuzhou, Guangzhou, Harbin
2026-04-01
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
26
Wuhan
2026-04-01
Not yet open
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
24
Xiamen, Zhengzhou, Qingdao
2026-04
Not yet open
Video Double-Lumen Tube for Secondary Pulmonary Resection
NCT07467005Lung Cancer, Pulmonary Nodule
Zhejiang University
Not applicable
500
Hangzhou, Yiwu
2026-03-16
Recruiting
Fudan University
Not applicable
1,036
Shanghai
2026-03-15
Recruiting
Guangzhou Concord Cancer Center
Not applicable
65
Guangzhou
2026-02-24
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Observational
14,300
Shijiazhuang, Zhengzhou, Changchun, Shenyang, Shanghai, Kunming
2026-02-05
Not yet open
Guangzhou Medical University
Not applicable
40
Guangzhou
2026-02-01
Recruiting
3H Pharmaceuticals Co., Ltd.
Phase 1/2
170
Beijing
2026-01-04
Recruiting
ePRO in Advanced Lung Cancer: Emotional Distress, Symptom Burden, Brain Metastasis
NCT07912190Lung Cancer, Brain Metastasis, Patient Reported Outcome
Qian Chu
Observational
200
Hubei
2026-01-04
Recruiting
Large Language Models Assist in Tumor MDT
NCT07504367Lung Cancer, Breast Cancer, Colorectal Cancer, Stomach Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
60
Guangzhou
2026-01-01
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
22
Chengdu
2025-12-10
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
100
Shanghai, Hangzhou
2025-12-04
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Observational
10,000
Zunyi, Jiangxi, Shanghai, Ningbo
2025-12-01
Not yet open
Tianjin Medical University Cancer Institute and Hospital
Phase 2
31
Tianjin
2025-12
Recruiting
Ruijin Hospital
Not applicable
90
Shanghai
2025-11-21
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
200
Guangzhou
2025-11-12
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
120
Hangzhou
2025-11-01
Recruiting
PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer
NCT07775820Lung Cancer, Rechallenge, Checkpoint Inhibitor Pneumonitis
Nanfang Hospital, Southern Medical University
Observational
150
Guangzhou, Shenzhen, Nanchang, Wenzhou
2025-10-20
Recruiting
VSV-02 Compassionate Use in Advanced Solid Tumors
NCT07260591Advanced Solid Tumor, Melanoma, Breast Cancer, Lung Cancer
The First Affiliated Hospital of Xinxiang Medical College
Phase 1
6
Xinxiang
2025-09-22
Recruiting
CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
NCT07179692Lung Cancer, Gastric Cancer, Colon Cancer, Rectal Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1
108
Hefei
2025-09-12
Recruiting
Anhui Provincial Hospital
Phase 1
20
Hefei
2025-09-01
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
210
Shanghai
2025-09-01
Recruiting
Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC
NCT07135856Lung Cancer, Neoadjuvant Therapy
Shanghai Chest Hospital
Observational
400
Shanghai
2025-09-01
Active, closed
Sir Run Run Shaw Hospital
Not applicable
5
Hangzhou
2025-09-01
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
149
Nanjing, Shanghai
2025-08-01
By invitation
Spontaneous Breathing Mode: A Risk for Hypoxemia During OLV?
NCT07494006Lung Cancer, OLV, Hypoxemia During Surgery
Peking University People's Hospital
Observational
44
Beijing
2025-07-15
Recruiting
Sichuan University
Phase 2
30
Chengdu
2025-07-04
Active, closed
Feasibility of Multi-cancer Early Detection Test in Screening Population (NQMD-CS)
NCT07834268Colorectal Cancer, Grastic Cancer, Esophageal Cancer, Lung Cancer
Fifth Affiliated Hospital of Guangzhou Medical University
Not applicable
1,250
Guangzhou, Huizhou
2025-07-02
Recruiting
Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors
NCT07058948Solid Cancers, Radiotherapy, Immune Checkpoint Inhibitor, Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
30
Beijing, Cangzhou, Tianjin
2025-07-01
Recruiting
Shanghai Chest Hospital
Not applicable
15
Shanghai
2025-05-12
Not yet open
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
66
Guanzhou
2025-04
Not yet open
Shanghai Chest Hospital
Phase 2
30
Shanghai
2025-03-31
Recruiting
Henan Cancer Hospital
Observational
20
Zhengzhou
2025-02-21
Recruiting
Shanghai Chest Hospital
Observational
50
Shanghai
2025-01-30
Not yet open
Second Affiliated Hospital of Soochow University
Not applicable
200
Suzhou
2025-01-18
Recruiting
Beidahuang Industry Group General Hospital
Not applicable
200
Harbin
2025-01-15
Recruiting
China-Japan Friendship Hospital
Observational
500
Beijing, Wuhan
2024-12-25
Recruiting
RenJi Hospital
Not applicable
100
Shanghai
2024-12-23
Active, closed
Merck Sharp & Dohme LLC
Phase 3
67
Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Huizhou, Jiangmen, Liuzhou
2024-11-21
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
22
Shanghai
2024-11-19
Recruiting
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
NCT07433283Tumor, Solid, Lung Cancer, Pancreas Cancer, Thyroid Cancer
Sichuan Enray Pharmaceutical Sciences Company
Phase 1/2
54
Beijing, Hunan, Chongqing, Fuzhou, Haikou, Heilongjiang, Shanghai, Chengdu
2024-11-12
Recruiting
Yunnan Cancer Hospital
Not applicable
195
Kunming
2024-11-11
Recruiting
The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer
NCT06975384Lung Cancer, Sleep Disturbance, Immune Checkpoint Inhibitors, Cancer, Treatment-Related
Second Xiangya Hospital of Central South University
Observational
1,270
Changsha
2024-11-01
Active, closed
Daiichi Sankyo
Phase 1/2
137
Changchun, Hangzhou, Harbin, Jiamusi, Shanghai, Tiyuan, Zhengzhou
2024-10-30
Recruiting
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
NCT06644430Advanced Hepatocellular Carcinoma, Lung Cancer, Oligometastasis, Ablation
Sun Yat-sen University
Observational
470
Beijing
2024-10-04
Recruiting
Zhou Chengzhi
Phase 1/2
20
Guangzhou
2024-09-01
Recruiting
Jiayuan Sun
Not applicable
110
Guangzhou, Zhengzhou, Shanghai, Chengdu, Hangzhou
2024-09-01
Recruiting
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Not applicable
100
Yiwu
2024-08-24
Recruiting
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
NCT06538012Lung Cancer, Lung Cancer Metastatic, Lung Cancer, Non-small Cell, Lung Cancer Recurrent
DrugsTumor Infiltrating Lymphocytes·Aldesleukin·Fludarabine·Cyclophosphamide
Essen Biotech
Phase 1/2
85
Beijing
2024-08-20
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
5,500
Guangzhou, Wuhan, Yangzhou, Shenyang, Chengdu, Hangzhou
2024-08-01
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
150
Wuhan
2024-07-02
Recruiting
Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.
NCT06492421Lung Cancer, Surgery, Non-small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 2
90
Guanzhou
2024-07-01
Recruiting
The Impact of AI Assistance on Radiologist Performance and Healthcare Costs in LDCT-Based Lung Cancer Screening
NCT06988579Lung Cancer, Artificial Intelligence (AI), Randomized Controlled Trial
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
7,294
Guangzhou
2024-07-01
Recruiting
ChromX Health
Observational
10,000
Guangzhou
2024-06-30
Recruiting
Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
NCT06518655Pulmonary Nodules, Multiple, Pulmonary Nodules, Solitary, Lung Cancer
ChromX Health
Observational
3,000
Beijing, Foshan, Guangzhou, Wuhan, Shanghai, Chengdu
2024-06-30
Not yet open
Shanghai Chest Hospital
Not applicable
10
Shanghai
2024-06-05
Recruiting
Qian Chu
Observational
100
Wuhan
2024-06-01
Recruiting
Jinghui Wang
Phase 2
30
Beijing
2024-05-17
Recruiting
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
NCT06196294Pancreas Cancer, Lung Cancer, Liver Cancer, Mesothelioma
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guangzhou
2024-05-10
Recruiting
Tang-Du Hospital
Not applicable
60
Xi'an
2024-05-01
Active, closed
AstraZeneca
Phase 2
76
Beijing, Changsha, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Nanning
2024-04-21
Recruiting
Sichuan University
Phase 1/2
45
Chengdu
2024-04-18
Recruiting
Kong Fanming
Not applicable
84
Tianjin
2024-04-17
Recruiting
Second Affiliated Hospital of Guangzhou Medical University
Phase 2
90
Guangzhou
2024-04-04
Recruiting
The First Affiliated Hospital of Guangzhou Medical University
Phase 2
51
Guangzhou
2024-04-01
Recruiting
Interventional Software for Multi-immunotherapy of Solid Tumors
NCT06478108Lung Cancer, Liver Cancer, Solid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3
60
Guangzhou
2024-04-01
Recruiting
Shanghai Chest Hospital
Not applicable
216
Shanghai
2024-03-24
Active, closed
Intuitive Surgical
Not applicable
354
Shanghai, Chengdu
2024-03-20
Recruiting
The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
NCT06244264Spinal Metastases, Blood Transfusion Complication, Lung Cancer, Surgery
Guangdong Provincial People's Hospital
Not applicable
118
Guangzhou
2024-03-15
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
20,000
Beijing
2024-03-01
Recruiting
Hematology department of the 920th hospital
Observational
1,000
Kunming
2024-03-01
Recruiting
Zhou Chengzhi
Phase 3
180
Guangzhou
2024-03-01
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
58
Shanghai
2024-02-02
Recruiting
Guangdong Provincial People's Hospital
Not applicable
100
Guangzhou
2024-01-23
Recruiting
The First Affiliated Hospital of Guangzhou Medical University
Observational
2,500
Guangzhou
2024-01-01
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Observational
2,000
Shanghai
2023-12-16
Recruiting
Peking Union Medical College Hospital
Not applicable
1,224
Beijing
2023-12-08
Recruiting
Liu Huang
Phase 2
25
Wuhan
2023-11-28
Recruiting
Assessment System of Sarcopenia in Lung Cancer Patients
NCT06327594Sarcopenia, Lung Cancer, Ultrasound
West China Hospital
Observational
1,500
Chengdu
2023-11-01
Not yet open
Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)
NCT06102161Lung Cancer, Wedge Resection, Ground-glass Opacity
Fudan University
Phase 3
286
Shanghai
2023-11
Recruiting
Xiangya Hospital of Central South University
Observational
64
Changsha
2023-10-30
Recruiting
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
20
Guangzhou
2023-09-15
Recruiting
Liu Huang
Observational
55
Wuhan
2023-08-04
Recruiting
Xinqiao Hospital of Chongqing
Not applicable
40
Chongqing
2023-08-01
Recruiting
Geneplus-Beijing Co. Ltd.
Observational
100
Shanghai
2023-06-19
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Observational
2,000
Shanghai
2023-05-25
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2
60
Beijing
2023-05-11
Recruiting
Shanghai University of Traditional Chinese Medicine
Not applicable
367
Shanghai
2023-05-01
Recruiting
GONGCHU Biotechnology Co., Ltd
Phase 1
21
Zhengzhou
2023-04-26
Active, closed
Qilu Pharmaceutical Co., Ltd.
Phase 3
606
Guangzhou
2023-02-15
Recruiting
Zhao Jun
Observational
50
Suzhou
2023-02-12
Active, closed
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
3,700
Hangzhou
2023-02-01
Recruiting
Chen KeZhong
Observational
1,800
Beijing
2022-12-31
Active, closed
AstraZeneca
Phase 2
47
Beijing, Changsha, Chongqing, Hangzhou, Jinan, Kunming, Nanchang, Ningbo
2022-11-15
Active, closed
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Observational
250
Yiwu
2022-10-15
Active, closed
Guangdong Association of Clinical Trials
Phase 3
192
Guangzhou
2022-06-20
Recruiting
Sun Yat-sen University
Observational
500
Guangzhou
2022-06-01
Active, closed
Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
NCT05092412Lung Cancer, Extensive-stage Small-cell Lung Cancer, Durvalumab
DrugDurvalumab
You Lu
Phase 2
30
Chongqing, Zhengzhou, Chengdu
2022-03-02
Recruiting
Shanghai Chest Hospital
Not applicable
100,000
Shanghai
2022-01-01
Recruiting
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
NCT05187338Lung Cancer, Liver Cancer, Colorectal Cancer, Pancreas Cancer
DrugsIpilimumab·Durvalumab·Pembrolizumab
Second Affiliated Hospital of Guangzhou Medical University
Phase 1/2
100
Guangzhou
2021-11-01
Recruiting
Hunan Province Tumor Hospital
Phase 3
12,000
Changsha
2021-10-01
Recruiting
Guangdong Provincial People's Hospital
Observational
300
Guangzhou
2021-09-01
Active, closed
Tang-Du Hospital
Phase 2
45
Xi'an
2021-03-01
Recruiting
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
50
Guangzhou
2021-03-01
Recruiting
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
NCT04842812Liver Cancer, Lung Cancer, Breast Cancer, Colo-rectal Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
40
Guangzhou
2021-01-01
Recruiting
The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)
NCT05477979Lung Cancer, Psychological Stress, Immune Checkpoint Inhibitors, Cancer, Treatment-Related
Second Xiangya Hospital of Central South University
Observational
750
Changsha
2020-06-01
Recruiting
Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
NCT04209218Lung Cancer, Surgery, Blood Pressure Management, Dexamethasone
DrugDexamethasone
Peking University First Hospital
Not applicable
1,988
Beijing
2020-04-07
Recruiting
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06255197Lung Cancer, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Non Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
60,000
Beijing
2019-11-04
Recruiting
The Second Hospital of Shandong University
Not applicable
350
Jinan
2019-10-08
Recruiting
LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
NCT06778512Lung, Lung Cancer, Cancer, NSCLC
The First Affiliated Hospital of Guangzhou Medical University
Observational
2,500
Guangzhou
2019-06-01
Recruiting
Guangdong Association of Clinical Trials
Observational
100
Guangzhou
2019-05-01
Recruiting
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
NCT06950697Lung Cancer, Venous Thromboembolism, Arterial Thromboembolism, Immune Checkpoint Inhibitors (ICIs)
Beijing Chao Yang Hospital
Observational
2,400
Zhengzhou, Hohhot, Beijing
2019-01-01
Recruiting
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3
200
Guanzhou
2018-11-01
Recruiting
Survival Outcomes of Lung Cancer
NCT03647098Lung Cancer
Hunan Province Tumor Hospital
Observational
20,000
Changsha
2018-08-01
Recruiting
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Observational
200
Yiwu
2018-01-01
Recruiting
iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray
NCT03192501Lung Cancer, Gene Abnormality, Gene Product Sequence Variation, Cancer
Second Affiliated Hospital of Guangzhou Medical University
Observational
250
Guangzhou
2017-07-01
Recruiting
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guangzhou
2017-07-01
Recruiting
Shanghai 10th People's Hospital
Observational
1,000
Ganzhou, Shanghai
2016-01
Recruiting
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
11,000
Guangzhou
2015-12-12
Active, closed
Academia Sinica, Taiwan
Observational
12,000
2014-10
Rows per page Showing 1–135 of 135
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/condition/lung-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 135 of those studies listing the condition Lung Cancer.

How many Lung Cancer trials are recruiting in China?

103 of the 135 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 17 have not yet opened recruitment, 14 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lung Cancer), 135 studies
PhaseStudiesRecruitingShare
Observational474234.8%
Not applicable382728.1%
Phase 2201314.8%
Phase 113109.6%
Phase 1/2976.7%
Phase 3624.4%
Phase 2/3221.5%

Most active sponsors

Lead sponsors with the most studies (Lung Cancer)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital of Guangzhou Medical University1010
Shanghai Chest Hospital96
Shanghai Pulmonary Hospital, Shanghai, China86
The First Affiliated Hospital of Guangzhou Medical University66
AstraZeneca53
Cancer Institute and Hospital, Chinese Academy of Medical Sciences33
Fudan University32
Guangdong Provincial People's Hospital33
Second Affiliated Hospital, Zhejiang University, School of Medicine32
The Fourth Affiliated Hospital of Zhejiang University School of Medicine32
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.